Hollings researchers uncovered data showing that women who survive cervical cancer are at greater risk of anal cancer years down the road.

A clinical trial at Hollings is looking for answers to a problem that Dr. Avi Siva saw was affecting her triple negative breast cancer patients.

MUSC study finds a link between inflammation and poor neonatal and pregnancy outcomes.

A new microcredential from Hollings Cancer Center highlights the work of future cancer researchers, who are learning both science and compassion.

MUSC Hollings Cancer Center researchers are working on a new drug that destroys cancer cells' energy factories.

New trial to test whether quit-smoking medication works to help people to quit vaping.

MUSC students receive world-class training and make worldwide connections at an international redox training program in Hungary.

MUSC student Thomas Blouin will use an NCI fellowship to study how a chemical that doesn't seem to change DNA still causes cancer.

MUSC researchers have engineered a new type of genetically modified immune cell that could help organ transplant patients who are prone to rejection.

Many people remain unaware that HPV can cause six types of cancer – and that can affect whether people choose to vaccinate.